{"id":"https://openalex.org/W2020620163","doi":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","title":"Human Brain \u03b3\u2010Aminobutyric Acid Levels and Seizure Control Following Initiation of Vigabatrin Therapy","display_name":"Human Brain \u03b3\u2010Aminobutyric Acid Levels and Seizure Control Following Initiation of Vigabatrin Therapy","alternate_titles":[],"publication_year":1996,"publication_date":"1996-12-01","ids":{"openalex":"https://openalex.org/W2020620163","doi":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","mag":"2020620163","pmid":"https://pubmed.ncbi.nlm.nih.gov/8931472"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.1996.67062399.x","doi":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020620163"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018643148","display_name":"Ognen A. C. Petroff","orcid":"https://orcid.org/0000-0003-2841-1533","observed_orcids":["https://orcid.org/0000-0003-2841-1533"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ognen A. C. Petroff","raw_affiliation_strings":["Department of Neurology, Yale University, New Haven, Connecticut 06510, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Yale University, New Haven, Connecticut 06510, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090099139","display_name":"Kevin L. Behar","orcid":"https://orcid.org/0000-0003-1467-0446","observed_orcids":["https://orcid.org/0000-0003-1467-0446"]},"institutions":[{"id":"https://openalex.org/I4210147155","display_name":"Pediatrics and Genetics","ror":"https://ror.org/03t432d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin L. Behar","raw_affiliation_strings":["Departments of Neurology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurology and","institution_ids":["https://openalex.org/I4210147155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004263035","display_name":"Richard H. Mattson","orcid":"https://orcid.org/0000-0002-6109-9003","observed_orcids":["https://orcid.org/0000-0002-6109-9003"]},"institutions":[{"id":"https://openalex.org/I4210147155","display_name":"Pediatrics and Genetics","ror":"https://ror.org/03t432d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard H. Mattson","raw_affiliation_strings":["Departments of Neurology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurology and","institution_ids":["https://openalex.org/I4210147155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046602530","display_name":"Douglas L. Rothman","orcid":"https://orcid.org/0000-0001-9321-4195","observed_orcids":["https://orcid.org/0000-0001-9321-4195"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Douglas L. Rothman","raw_affiliation_strings":["Medicine, Yale University, New Haven, Connecticut, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Yale University, New Haven, Connecticut, U.S.A","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018643148"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":3.6227,"has_fulltext":false,"cited_by_count":91,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92988563,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"67","issue":"6","first_page":"2399","last_page":"2404"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.9829999804496765},{"id":"https://openalex.org/keywords/brain-gaba-levels","display_name":"brain GABA levels","score":0.9309999942779541},{"id":"https://openalex.org/keywords/seizure-control","display_name":"seizure control","score":0.9649999737739563},{"id":"https://openalex.org/keywords/complex-partial-seizures","display_name":"complex partial seizures","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6629999876022339},{"id":"https://openalex.org/keywords/occipital-lobe","display_name":"occipital lobe","score":0.8799999952316284},{"id":"https://openalex.org/keywords/gaba-synthesis","display_name":"GABA synthesis","score":0.8429999947547913},{"id":"https://openalex.org/keywords/1h-nmr-spectroscopy","display_name":"1H NMR","score":0.7870000004768372},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.994978666305542},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5813910365104675},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5472873449325562},{"id":"https://openalex.org/C2779414652","wikidata":"https://www.wikidata.org/wiki/Q3604505","display_name":"Aminobutyric acid","level":3,"score":0.5388803482055664},{"id":"https://openalex.org/C2777771985","wikidata":"https://www.wikidata.org/wiki/Q210021","display_name":"gamma-Aminobutyric acid","level":3,"score":0.5138478875160217},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.47721797227859497},{"id":"https://openalex.org/C2778046553","wikidata":"https://www.wikidata.org/wiki/Q848340","display_name":"Occipital lobe","level":2,"score":0.44514650106430054},{"id":"https://openalex.org/C2781099131","wikidata":"https://www.wikidata.org/wiki/Q744385","display_name":"Temporal lobe","level":3,"score":0.4229063093662262},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4108516275882721},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3991831839084625},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3942563235759735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3892918825149536},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33509010076522827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32785552740097046},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.30152592062950134},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.069176584482193}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009778","descriptor_name":"Occipital Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009778","descriptor_name":"Occipital Lobe","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013057","descriptor_name":"Spectrum Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017029","descriptor_name":"Epilepsy, Complex Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017029","descriptor_name":"Epilepsy, Complex Partial","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.1996.67062399.x","doi":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1996.67062399.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:8931472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8931472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1602659948","display_name":"1H NMR MEASUREMENTS OF BRAIN GABA CONCENTRATION","funder_award_id":"R29NS032126","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G3168338616","display_name":"HUMAN CEREBRAL GABA METABOLISM STUDIED IN VIVO WITH NMR","funder_award_id":"R01NS032518","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8333185633","display_name":null,"funder_award_id":"P01-NSO6208","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2051806609","https://openalex.org/W2004043769","https://openalex.org/W2121694953","https://openalex.org/W2024435902","https://openalex.org/W2040951012","https://openalex.org/W1981924762","https://openalex.org/W2071135238","https://openalex.org/W2083651237","https://openalex.org/W2113159807","https://openalex.org/W2060714844"],"abstract_inverted_index":{"Vigabatrin":[0],"is":[1,19,27],"a":[2,59,72,98],"novel":[3],"antiepileptic":[4,204],"drug":[5],"designed":[6,206],"to":[7,69,97,109,138,142,207],"control":[8,18,146,171,201],"seizures":[9],"by":[10,133],"raising":[11],"brain":[12,111,124,157,183,209],"gamma-aminobutyric":[13],"acid":[14],"(GABA)":[15],"concentrations.":[16],"Seizure":[17],"not":[20,148],"improved":[21,163,169,199],"significantly":[22],"when":[23,173,202],"the":[24,52,76,91],"daily":[25,99],"dose":[26,100,107],"increased":[28,89,176],"beyond":[29],"50":[30],"mg/kg.":[31,103],"Serial,":[32],"in":[33,39,75,106,182],"vivo":[34],"measurements":[35],"of":[36,54,79,93,101,122,153],"GABA":[37,87,112,115,125,158,174,184,195,210],"levels":[38,175],"human":[40,123],"occipital":[41,77,193],"lobe":[42,78,194],"were":[43],"made":[44],"using":[45,203],"1H":[46],"NMR":[47],"spectroscopy":[48],"before":[49],"and":[50,64],"after":[51],"start":[53,92],"vigabatrin":[55,94,128,154,167],"treatment.":[56],"We":[57],"used":[58],"2.1-T":[60],"magnetic":[61],"resonance":[62],"imagerspectrometer":[63],"an":[65],"8-cm":[66],"surface":[67],"coll":[68],"examine":[70],"serially":[71],"14-cm3":[73],"volume":[74],"26":[80],"patients":[81],"with":[82,119,150,162],"complex":[83],"partial":[84],"seizures.":[85],"Brain":[86],"content":[88,113,185],"following":[90],"treatment":[95,129,168],"up":[96],"60":[102],"Additional":[104],"increases":[105,152,181],"falled":[108],"increase":[110,208],"further.":[114],"synthesis":[116],"may":[117,197],"decrease":[118],"sustained":[120],"elevations":[121],"levels.":[126,211],"Starting":[127,166],"reduced":[130],"seizure":[131,145,164,170,200],"frequency":[132],">":[134],"50%,":[135],"from":[136],"six":[137],"seven":[139],"per":[140],"month":[141],"three.":[143],"Improved":[144],"was":[147,160],"associated":[149,161],"further":[151],"dose.":[155],"Increased":[156],"concentration":[159],"control.":[165],"twofold":[172],"above":[177,186],"1.8":[178],"mmol/kg.":[179],"Further":[180],"2.5":[187],"mmol/kg":[188],"provided":[189],"less":[190],"protection.":[191],"Measuring":[192],"concentrations":[196],"predict":[198],"drugs":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020620163","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
